Macrogenics (MGNX) Retained Earnings (2012 - 2026)
Macrogenics' (MGNX) quarterly Retained Earnings came in at -$1.3 billion in Q1 2026, down 5.81% year-on-year from -$1.4 billion in Q1 2025, and down 2.96% on a QoQ basis from -$1.2 billion in Q4 2025.
Macrogenics (MGNX) Retained Earnings (2012 - 2026) Analysis & Trends
Macrogenics (MGNX) has 15 years of Retained Earnings data on file, last reported at -$1.3 billion in Q1 2026.
- On a quarterly basis, Retained Earnings fell 5.81% year-over-year to -$1.3 billion in Q1 2026; TTM through Mar 2026 was -$1.3 billion, a 5.81% decrease from a year earlier, with the FY2025 full-year figure at -$1.2 billion, down 6.38% from the prior year.
- Retained Earnings for Q1 2026 stood at -$1.3 billion, down from -$1.2 billion in the prior quarter.
- Over the last five years, Retained Earnings for MGNX reached as high as -$1.0 billion in Q1 2022 and fell as low as -$1.3 billion in Q1 2026.
- Historically, Retained Earnings has averaged -$1.2 billion across 5 years, with a median of -$1.2 billion in 2024.
- Across the five-year window, Retained Earnings declined 26.4% in 2022 and advanced 4.5% in 2023, its largest moves.
- Year by year, Retained Earnings stood at -$1.1 billion in 2022, then declined by 0.83% to -$1.1 billion in 2023, then slipped by 6.07% to -$1.2 billion in 2024, then dropped by 6.38% to -$1.2 billion in 2025, then retreated by 2.96% to -$1.3 billion in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were -$1.3 billion in Q1 2026, -$1.2 billion in Q4 2025, and -$1.2 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Macrogenics | 254.43 Mn | 187.92 Mn | - | -1.28 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.28 Bn |
| Dec 31, 2025 | -1.24 Bn |
| Sep 30, 2025 | -1.23 Bn |
| Jun 30, 2025 | -1.25 Bn |
| Mar 31, 2025 | -1.21 Bn |
| Dec 31, 2024 | -1.17 Bn |
| Sep 30, 2024 | -1.15 Bn |
| Jun 30, 2024 | -1.21 Bn |
| Mar 31, 2024 | -1.15 Bn |
| Dec 31, 2023 | -1.10 Bn |
| Sep 30, 2023 | -1.06 Bn |
| Jun 30, 2023 | -1.07 Bn |
| Mar 31, 2023 | -1.13 Bn |
| Dec 31, 2022 | -1.09 Bn |
| Sep 30, 2022 | -1.11 Bn |
| Jun 30, 2022 | -1.08 Bn |
| Mar 31, 2022 | -1.04 Bn |
| Dec 31, 2021 | -973.94 Mn |
| Sep 30, 2021 | -915.91 Mn |
| Jun 30, 2021 | -863.03 Mn |